Clin2
NCT06749678Possibly a fitNot yet recruiting

Prehabilitation before liver cancer conversion therapy

Advanced Hepatocellular Carcinoma (HCC)Prehabilitation

Part of Cancer, Digestive system clinical trials.

This study tests whether a pre-surgery exercise and nutrition program (prehabilitation) can improve recovery outcomes for people with liver cancer that cannot be surgically removed right away. The goal is to help you become stronger before planned treatment to shrink the tumor.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
84 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with liver cancer (hepatocellular carcinoma) that cannot be removed with surgery and are planning to receive treatment to shrink it (conversion therapy).
  • You are able to walk for more than 200 meters without stopping and climb two flights of stairs without a break.
  • You do not have cancer that has spread to other organs, another type of cancer, or a serious heart, lung, or kidney condition.
  • You are not pregnant or breastfeeding, and you do not have a mental health condition that would make it hard to follow instructions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04520737Recruiting
Exercise coaching during chemotherapy for liver metastases

This trial studies whether a “prehab” program—structured exercise and preparation—can help people keep up function while they are on chemotherapy for colorectal cancer that has spread to the liver. If you can safely exercise, the program may help you tolerate treatment and stay active.

Tarragona
NCT07501351Recruiting· Phase 2
Comparing two therapies for advanced liver cancer after first treatment fails

This trial tests if a more intensive treatment is better than switching to another therapy for people with advanced liver cancer (HCC) that got worse after a first treatment with bevacizumab and sintilimab. It aims to find a more effective option for patients who need a next step.

Guangzhou, Guangdong
NCT06492408Recruiting· Phase 2
Immunotherapy before surgery for liver cancer

This trial tests giving two immunotherapy drugs directly into the tumor before surgery for liver cancer. It aims to see if this approach can shrink the tumor and improve outcomes for patients who are candidates for surgery.

Guanzhou, Guangdong
NCT06405321Recruiting
Initial therapy before surgery for liver cancer

This trial looks at how well certain initial treatments (like targeted therapy, immunotherapy, or liver-directed procedures) work in people with liver cancer who have not had surgery yet. It aims to see if these treatments can shrink the tumor enough to allow removal later.

Nanning, China
NCT07537205Enrolling by invitation
Nurse-led preparation program for liver cancer surgery

This study tests whether a personalized preparation program led by nurses before liver cancer surgery helps patients recover better and have fewer complications. The program is designed specifically for people scheduled to have part of their liver removed.

Shanghai, Xuhui
NCT04246970Enrolling by invitation
Training program before and after liver transplant

This trial studies a structured exercise and training program before and after liver transplantation to help people recover better. You may be able to benefit if you’re getting an elective liver transplant and can safely participate in the training plan.

Valencia, Valencia

Hear when a new Advanced Hepatocellular Carcinoma (HCC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.